Invention Grant
- Patent Title: Lipidated peptides as anti-obesity agents
-
Application No.: US14414034Application Date: 2013-07-11
-
Publication No.: US09937235B2Publication Date: 2018-04-10
- Inventor: Lenka Maletinska , Blanka Zelezna , Miroslava Blechova , Andrea Popelova
- Applicant: USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR, V.V.I
- Applicant Address: CZ Prague
- Assignee: USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR, V.V.I.
- Current Assignee: USTAV ORGANICKE CHEMIE A BIOCHEMIE AKADEMIE VED CR, V.V.I.
- Current Assignee Address: CZ Prague
- Agency: Notaro, Michalos & Zaccaria P.C.
- Priority: CZ2012-476 20120712
- International Application: PCT/IB2013/001837 WO 20130711
- International Announcement: WO2014/009808 WO 20140116
- Main IPC: A61K38/00
- IPC: A61K38/00 ; A61K38/22 ; C07K14/575 ; A61K47/54

Abstract:
Lipidated peptides, analogs of both forms of the prolactin-releasing peptide, PrRP31 and PrRP20, represent anorexigenic compounds that lower food intake and function in the brain after peripheral administration. The analogs PrRP31 and PrRP20 lipidated at the N-terminus by myristic or palmitic acids bind with high affinity to the endogenous receptor GPR10 in the rat pituitary cell line RC-4B/C and CHO cell line with transfected human receptor. These lipidated peptides also significantly decrease, in a dose-dependent manner, the food intake in fasted mice and have similar effects in comparable doses as centrally administered natural PrRP31, these effects are, however, stronger and longer lasting. Lipidation of an effective anorexigenic neuropeptide PrRP induces a central effect after peripheral administration and thus makes the lipidated analogs of PrRP a promising anti-obesity drug.
Public/Granted literature
- US20150175674A1 LIPIDATED PEPTIDES AS ANTI-OBESITY AGENTS Public/Granted day:2015-06-25
Information query
IPC分类: